KEVIN WETHEY: Open Payments
NPI 1306378559 · DIAMOND BAR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 39 payments from 12 companies in 2025. Trend: 2023 $68 · 2024 $476 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $254 |
| Alkermes, Inc. | 5 | $138 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
Products named: VRAYLAR, ARISTADA, Auvelity, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across CA — which companies pay providers there.
